ASCO 2022 Conference Coverage


 

Lecture Summary - ASCO 2022: The ImPrint Immune Signature to Identify Patients With High-Risk eBC Who May Benefit From PD-1 Checkpoint Inhibition in I-SPY2

37 views
June 8, 2022
Comments 0
Login to view comments. Click here to Login